Overview

Corporate Overview

Compugen is a clinical-stage drug discovery and development company utilizing a broadly applicable, predictive computational discovery platform to identify novel drug targets and new biological pathways and develop therapeutics in the field of cancer immunotherapy. Recognizing the potential of immuno-oncology to shift the cancer treatment landscape, we chose to focus on the discovery of new drug targets to extend the reach of cancer immunotherapies to new patient populations.